These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7863467)

  • 41. Role of the kringle domain in plasminogen activation with staphylokinase.
    Arai K; Madoiwa S; Mimuro J; Asakura S; Matsuda M; Sako T; Sakata Y
    J Biochem; 1998 Jan; 123(1):71-7. PubMed ID: 9504411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1988 Jan; 49(2):253-63. PubMed ID: 3129817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of staphylokinase in the acquisition of plasmin(ogen)-dependent enzymatic activity by staphylococci.
    Christner RB; Boyle MD
    J Infect Dis; 1996 Jan; 173(1):104-12. PubMed ID: 8537646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Domain interactions between streptokinase and human plasminogen.
    Loy JA; Lin X; Schenone M; Castellino FJ; Zhang XC; Tang J
    Biochemistry; 2001 Dec; 40(48):14686-95. PubMed ID: 11724583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NH2-terminal structural motifs in staphylokinase required for plasminogen activation.
    Schlott B; Gührs KH; Hartmann M; Röcker A; Collen D
    J Biol Chem; 1998 Aug; 273(35):22346-50. PubMed ID: 9712854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An anti-plasminogen antibody preparation that inhibits the activation of human plasminogen but enhances the activator activity of the B-chain-streptokinase complex.
    Summaria L; Pavlovic B; Sandesara J
    Thromb Res; 1989 Apr; 54(1):1-15. PubMed ID: 2727955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipid modification of staphylokinase and its implications on stability and activity.
    Mannully ST; Shanthi C; Pulicherla KK
    Int J Biol Macromol; 2019 Jan; 121():1037-1045. PubMed ID: 30342946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kinetic properties of the activator complexes plasmin--staphylokinase and plasmin(ogen)--streptokinase in vitro.
    Sazonova IY; Aisina RB; Muhametova LI; Varfolomeyev SD
    Biochemistry (Mosc); 1999 Jan; 64(1):66-74. PubMed ID: 9986915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of the activation of Glu-plasminogen by urokinase in the simultaneous presence of tranexamic acid or fibrin.
    Takada A; Sugawara Y; Takada Y
    Haemostasis; 1989; 19(1):26-31. PubMed ID: 2920977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections.
    Peetermans M; Vanassche T; Liesenborghs L; Claes J; Vande Velde G; Kwiecinksi J; Jin T; De Geest B; Hoylaerts MF; Lijnen RH; Verhamme P
    BMC Microbiol; 2014 Dec; 14():310. PubMed ID: 25515118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integration of VEK-30 peptide enhances fibrinolytic properties of staphylokinase.
    Bhando T; Singh S; Hade MD; Kaur J; Dikshit KL
    Biotechnol Appl Biochem; 2021 Apr; 68(2):213-220. PubMed ID: 32233032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of site-specific PEGylation on the fibrinolytic activity, immunogenicity, and pharmacokinetics of staphylokinase.
    Liu J; Wang Z; He J; Wang G; Zhang R; Zhao B
    Acta Biochim Biophys Sin (Shanghai); 2014 Sep; 46(9):782-91. PubMed ID: 25098624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]- and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain.
    Horrevoets AJ; Pannekoek H; Nesheim ME
    J Biol Chem; 1997 Jan; 272(4):2183-91. PubMed ID: 9036151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrin binding of plasminogen coated liposomes in vitro.
    Heeremans JL; Los P; Prevost R; Crommelin DJ; Kluft C
    Thromb Haemost; 1996 Jan; 75(1):134-9. PubMed ID: 8713792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fibrin-dependent activation of plasminogen by a proteolytic digest of streptokinase.
    Nakashima A; Okada T; Sugie I
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):279-84. PubMed ID: 2103312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of carbohydrate side chains of plasminogen in its activation by staphylokinase.
    Aisina R; Mukhametova L; Gershkovich K; Varfolomeyev S
    Biochim Biophys Acta; 2005 Oct; 1725(3):370-6. PubMed ID: 16176856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The activation of two isozymes of glu-plasminogen (I and II) by urokinase and streptokinase.
    Takada A; Takada Y
    Thromb Res; 1983 Jun; 30(6):633-42. PubMed ID: 6351345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional properties of a novel mutant of staphylokinase with platelet-targeted fibrinolysis and antiplatelet aggregation activities.
    Chen H; Mo W; Zhang Y; Su H; Ma J; Yao R; Zhang S; Ge J; Song H
    Eur J Pharmacol; 2007 Jul; 566(1-3):137-44. PubMed ID: 17451675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of staphylokinase-dependent plasminogen activation by mono- and divalent ions.
    Yarzábal A; Serrano RL; Puig J
    Braz J Med Biol Res; 1999 Jan; 32(1):39-43. PubMed ID: 10347766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Staphylokinase-annexin XI chimera exhibited efficient in vitro thrombolytic activities.
    Chiou JF; Woon MD; Cheng SN; Hsu CH; Cherng SC; Hsieh FK; Lin SM; Shiau CY
    Biosci Biotechnol Biochem; 2007 May; 71(5):1122-9. PubMed ID: 17485856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.